Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark Cookson
Nature reviews. Neuroscience (2010) Vol. 11, Iss. 12, pp. 791-797
Open Access | Times Cited: 522

Showing 1-25 of 522 citing articles:

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Nicole Exner, A. Kathrin Lutz, Christian Haass, et al.
The EMBO Journal (2012) Vol. 31, Iss. 14, pp. 3038-3062
Open Access | Times Cited: 567
NAD+ in Brain Aging and Neurodegenerative Disorders
Sofie Lautrup, David Sinclair, Mark P. Mattson, et al.
Cell Metabolism (2019) Vol. 30, Iss. 4, pp. 630-655
Open Access | Times Cited: 550
Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
Adriana Sánchez‐Danés, Yvonne Richaud‐Patín, Iria Carballo‐Carbajal, et al.
EMBO Molecular Medicine (2012) Vol. 4, Iss. 5, pp. 380-395
Open Access | Times Cited: 539
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
Oliver Cooper, Hyemyung Seo, Shaida A. Andrabi, et al.
Science Translational Medicine (2012) Vol. 4, Iss. 141
Open Access | Times Cited: 482
Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
Peter Reinhardt, Benjamin Schmid, Lena F. Burbulla, et al.
Cell stem cell (2013) Vol. 12, Iss. 3, pp. 354-367
Closed Access | Times Cited: 479
A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
Egon Deyaert, Lina Wauters, Giambattista Guaitoli, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 465
Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis
Martin Steger, Federico Diez, Herschel S. Dhekne, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 442
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson’s Disease
Chung-Han Hsieh, Atossa Shaltouki, Ashley E. Gonzalez, et al.
Cell stem cell (2016) Vol. 19, Iss. 6, pp. 709-724
Open Access | Times Cited: 422
Recent Advances in the Genetics of Parkinson's Disease
Ian Martin, Valina L. Dawson, Ted M. Dawson
Annual Review of Genomics and Human Genetics (2011) Vol. 12, Iss. 1, pp. 301-325
Open Access | Times Cited: 418
Mitochondrial Diseases of the Brain
Rajnish Kumar Chaturvedi, M. Flint Beal
Free Radical Biology and Medicine (2013) Vol. 63, pp. 1-29
Closed Access | Times Cited: 394
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1
Xinglong Wang, Yan Ma, Hisashi Fujioka, et al.
Human Molecular Genetics (2012) Vol. 21, Iss. 9, pp. 1931-1944
Open Access | Times Cited: 385
Ser 1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng, Shuo Zhang, Daisy Bustos, et al.
Science Translational Medicine (2012) Vol. 4, Iss. 164
Closed Access | Times Cited: 356
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
A Beilina, Iakov N. Rudenko, Alice Kaganovich, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 7, pp. 2626-2631
Open Access | Times Cited: 349
LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
Martin C. Herzig, Carine Kolly, Elke Persohn, et al.
Human Molecular Genetics (2011) Vol. 20, Iss. 21, pp. 4209-4223
Open Access | Times Cited: 343
LRRK2 Controls an EndoA Phosphorylation Cycle in Synaptic Endocytosis
Samer Matta, Kristof Van Kolen, Raquel da Cunha, et al.
Neuron (2012) Vol. 75, Iss. 6, pp. 1008-1021
Open Access | Times Cited: 334
Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
Micah J. Niphakis, Benjamin F. Cravatt
Annual Review of Biochemistry (2014) Vol. 83, Iss. 1, pp. 341-377
Open Access | Times Cited: 333
Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
Reina N. Fuji, Michael Flagella, Miriam Baca, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 273
Closed Access | Times Cited: 330
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Guang‐Hui Liu, Jing Qu, Keiichiro Suzuki, et al.
Nature (2012) Vol. 491, Iss. 7425, pp. 603-607
Open Access | Times Cited: 324
Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease
Lorraine V. Kalia, Anthony E. Lang, Lili‐Naz Hazrati, et al.
JAMA Neurology (2014) Vol. 72, Iss. 1, pp. 100-100
Open Access | Times Cited: 316
Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders
Karen Doyle, Donna Kennedy, Adrienne M. Gorman, et al.
Journal of Cellular and Molecular Medicine (2011) Vol. 15, Iss. 10, pp. 2025-2039
Open Access | Times Cited: 310
The role of FUS gene variants in neurodegenerative diseases
Hao Deng, Kai Gao, Joseph Jankovic
Nature Reviews Neurology (2014) Vol. 10, Iss. 6, pp. 337-348
Closed Access | Times Cited: 310
Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases
Daniel W. Neef, Alex M. Jaeger, Dennis J. Thiele
Nature Reviews Drug Discovery (2011) Vol. 10, Iss. 12, pp. 930-944
Open Access | Times Cited: 288
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
Matthew Fell, Christian Mirescu, Kallol Basu, et al.
Journal of Pharmacology and Experimental Therapeutics (2015) Vol. 355, Iss. 3, pp. 397-409
Open Access | Times Cited: 279
Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi, Thirumahal Selvanantham, Erika Swinton, et al.
Journal of Neural Transmission (2011) Vol. 118, Iss. 5, pp. 795-808
Open Access | Times Cited: 261
Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014
Marie Villumsen, Susana Aznar, Bente Pakkenberg, et al.
Gut (2018) Vol. 68, Iss. 1, pp. 18-24
Open Access | Times Cited: 260
Page 1 - Next Page

Scroll to top